Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE
**************************************************************************
FOR IMMEDIATE RELEASE
Xechem Announces Launch of Nicosan™ (formerly "Niprisan") A Treatment for Sickle Cell Disease
NEW BRUNSWICK, NEW JERSEY, Feb. 3 -/E-Wire/-- Xechem International, Inc. (OTC BB: ZKEM) announced today that it anticipates the initial sales of NICOSAN™, its Sickle Cell Anemia Drug for distribution in Nigeria in late March or early April 2003, through its subsidiary ("Xechem Nigeria"). Xechem Pharmaceuticals Nigeria Limited is organized under the Companies and Allied Matters Act (1992) of the Federal Republic of Nigeria.
All manufacturing, marketing, distribution and sales of the product NICOSAN™ will take place through Xechem Nigeria at this time. This will place Xechem in a unique position to take full advantage of Nigeria's well-known biodiversity, which is expected to yield many new, important drugs and other phyto-pharmaceutical products.
On July 18, 2002, Xechem International, Inc. signed an exclusive worldwide license for the manufacturing, marketing, distribution and sales of NIPRISAN™ from the National Institute of Pharmaceutical Research and Development ("NIPRD"), government of Nigeria, for the treatment of Sickle Cell Disease ("SCD"). NICOSAN™ is Xechem's name for the non-toxic phyto-pharmaceutical product formerly named NIPRISAN™. Xechem is currently in the process of completing for submission of an Investigational New Drug Application ("IND") for this product to the United States Food and Drug Administration ("FDA"). To date, there has been no successful non-toxic drug developed for the treatment of SCD.
According to Xechem's President and CEO, Dr. Ramesh C. Pandey, "Xechem is in position to take advantage of the extraordinary biodiversity of Nigeria and the African continent. Our ability to develop life saving and life extending medicinal products from natural sources is evident in our history as a company as well as our commitment to work hand in hand with the government of Nigeria. Currently over 25% of the Nigerian population is a carrier of SCD and over 6.4 million Nigerians, 5% of the population are afflicted with this horribly painful disease."
Xechem International, Inc., headquartered in New Brunswick, N.J., with subsidiary companies in the USA, India, Nigeria and joint venture partners in both Hong Kong and the Peoples Republic of China, is a biopharmaceutical engaged in the research, development and production of generic and proprietary drugs from natural sources. The company specializes in the development of niche-generic, difficult to replicate, anti-cancer, antiviral compounds, including Human Immuno-deficiency Virus ("HIV") and anti-fungal compounds. Xechem is also engaged in the research and development of several novel anti-infectives showing strong and selective efficacy against an array of antibiotic resistant bacterias, including Helicobacter pylori (H. pylori), Vancomycin resistant Enterococcus faecalis (VREF), Methicillin resistant Staphylococcus aureus (MRSA), and other antibiotic resistant Staphylococcus aureus and Candida albicans. The Company also screens extracts and pure compounds from various parts of the world for their therapeutic use.
XetaPharm (another U.S. subsidiary) develops quality controlled nutritional products such as GinkgoOnce®, GinsengOnce®, GarlicOnce®, Gugulon™, VIDA PRAS™ and numerous other nutraceutical products, which are under development.
This and past press releases of Xechem International, Inc. are available at Xechem's web site at www.xechem.com.
This news release may contain certain forward-looking statements relating to Xechem's future business performance within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks, uncertainties, including the ability of the Companies to successfully develop and commercialize their technologies, and other factors that may cause the actual results, performance or achievements of the Companies to be materially different from any future results, performance or achievements of the Companies expressed or implied by such forward-looking statements.
*****someone posted this link on another board maybe it could get cleared up by someone
Did an incredible amount of volume today. wonder what volume will be tomorrow? couldnt be anywhere this high unless we get the same amount of buyers and everyone thats long sells imo
XKEM MOOOOOOOOOOOOOO buy during lunch imo possibly .05 close!
clost between .046-.05 imo we could see .10+ in july
NO you READ "Chassman has agreed to extend the due date on all existing notes held by the Company to May 31, 2008"
WRONG xkem OS/FLOAT=1,093,471,115 shares. i even asked steve myself last friday he said it hasnt changed, there have been no shares added
this stock will close in the .046-.05 range imo
XKEM yup its just getting started .10+ target in July
XKEM will break .04 !!! like a paper wall!!!
OTC world getting into XKEM first!!
Hold this gem till JULY =).eom
looks like XKEM breaking over .04 today
Posted by: jcald
In reply to: pfrenz who wrote msg# 645103 Date:6/22/2006 12:44:24 AM
Post #of 645111
Posted by: pfrenz
In reply to: fourrwinns who wrote msg# 645093 Date:6/22/2006 12:39:07 AM
Post #of 645110
hey fourrwinns, weren't you the one telling me this morning that you wouldn't buy XKEM @.03, and I totally agreed with you?.....LOL
Posted by: pfrenz
In reply to: fourrwinns who wrote msg# 645093 Date:6/22/2006 12:39:07 AM
Post #of 645110
hey fourrwinns, weren't you the one telling me this morning that you wouldn't buy XKEM @.03, and I totally agreed with you?.....LOL
toooo funny
article was missed because they spelled nicosan as nicosam, so when people google it they never get anything
Everyone read XKEM article ? LINK:http://www.thisdayonline.com/nview.php?id=50861
everyone read the article on XKEM & nigeria? big news
deh pinga monster stock da-LEH!.EOM
XKEMMMMMMMMMMMMMMMMMMMM =)
you sound like a pro, stick around kid you might soon be called 5wins.eom
make it a green close =)
Bridge loan financing is an effective vehicle to immediately capitalize on a purchase opportunity. *****It is a form of short-term financing which is expected to be paid back - generally within the range of 6 to 36 months******* - once the borrower obtains more permanent, lower cost financing.
could be a rich lady that is close to a scd sufferer
why would i want to pay? thats ridiculous, mb's are ridiculous there just places to talk about stocks, so many of them out there. ihub profiting off fools.eom
give me a break mackie! fool.eom
AHAHAHAHA thanks for the shares @ .0285!!!
Statements like these show how uninformed some investors are...pretty sad and pathetic that they cant read a little 8k..
scarecrow, read:In addition, Chassman has agreed to extend the due date on all existing notes held by the Company to May 31, 2008.
still no dilutioN!!! IDIOTSS!!!! its a loan will be paid way before 08! with little interest!!!
scarecrow, i dont know what the fuss is about, we have 2 years to pay back the loan!
more funding for production!!! conversion in 08!! chassman gonna be arich man in 2 years!!!
GREAT NEWS! Chassman agreed to extend the due date to 08!! i see buying tomorrow
well at least this company is a real deal.
Posted by: joyride
In reply to: None Date:6/11/2006 10:35:29 PM
Post #of 6127
It warms my heart to see the bashers so concerned about my money, and to see such selfless advice given to watch over the XKEM shareholders.
I'm getting all choked up...
Posted by: joyride
In reply to: JusDePomme who wrote msg# 5759 Date:6/19/2006 2:17:57 PM
Post #of 6128
JusdePomme: Who cares what goes on at Raging Bull? It's a stock forum for losers, bashers, and amateurs. It's not an arena of ideas or opportunity, but rather one of ignorance and insults.
Anyone who is halfway serious has left and come to this forum, or has started their own forum.
*****YOUD BE RIGHT AT HOME! LOL***************
Posted by: joyride
In reply to: block911 who wrote msg# 4393 Date:6/11/2006 10:19:14 PM
Post #of 6124
This stock is going to do really well. The bashers are already stalking XKEM's offices, taking fuzzy pictures.
I think I'm buying more in the morning
so far trading pattern changed today we may see a different close too, stay tuned
XKEM hands down.eom
looks like another green day ahead =)
market cap should be at LEAST 100 million
gap filled...going up?